Okuda A, Kimura G
Department of Virology, Kyushu University, Fukuoka.
Jpn J Cancer Res. 1989 May;80(5):452-8. doi: 10.1111/j.1349-7006.1989.tb02335.x.
The possibility of selective killing of transformed cells in a mixed population of untransformed and transformed cells was examined using a cell culture system of rat 3Y1 fibroblasts (parental 3Y1 cells, 3Y1 cells transformed with either SV40, polyoma virus, Rous avian sarcoma virus, E1A gene of adenovirus type 12, or H-v-ras oncogene). The principle of the selective killing is as follows. Under suboptimal culture conditions, untransformed cells are inhibited from progressing through G1 phase and retain viability, while transformed cells are not arrested. When DNA synthesis is inhibited for a long period, both types of cells in S phase die. Therefore, if we administer inhibitors of G1 progression and of DNA synthesis simultaneously to a cell population consisting of untransformed and transformed cells, most untransformed cells are arrested in G1 phase, retaining viability, while transformed cells leak from the G1 phase, cease DNA synthesis, and gradually die The present study shows that all types of transformants in stationary-phase cultures (consisting of cells mainly with a G1 DNA content) were killed to higher extents compared with untransformed cells, during incubation at lower cell densities with a combination of cycloheximide (G1 inhibitor) and aphidicolin (DNA-synthesis inhibitor). However, cycloheximide reduced the killing effect of aphidicolin by changing the irreversible DNA-synthesis inhibition to a reversible inhibition. The availability of G1 inhibitors that do not interfere with the irreversibility of inhibition of DNA synthesis is required for the treatment of cancer based on this idea.
利用大鼠3Y1成纤维细胞的细胞培养系统(亲代3Y1细胞、用SV40、多瘤病毒、劳氏禽肉瘤病毒、12型腺病毒E1A基因或H - v - ras癌基因转化的3Y1细胞),研究了在未转化细胞和转化细胞的混合群体中选择性杀死转化细胞的可能性。选择性杀伤的原理如下。在次优培养条件下,未转化细胞在G1期的进程受到抑制并保持活力,而转化细胞则不会停滞。当DNA合成被长期抑制时,处于S期的两种细胞都会死亡。因此,如果我们同时将G1期进程抑制剂和DNA合成抑制剂应用于由未转化细胞和转化细胞组成的细胞群体,大多数未转化细胞会停滞在G1期并保持活力,而转化细胞则从G1期漏出,停止DNA合成并逐渐死亡。本研究表明,在较低细胞密度下,用环己酰亚胺(G1抑制剂)和阿非迪霉素(DNA合成抑制剂)联合孵育时,与未转化细胞相比,处于静止期培养(主要由具有G1期DNA含量的细胞组成)的所有类型的转化体被杀死的程度更高。然而,环己酰亚胺通过将不可逆的DNA合成抑制转变为可逆抑制,降低了阿非迪霉素的杀伤效果。基于这一理念的癌症治疗需要有不干扰DNA合成抑制不可逆性的G1抑制剂。